Insider · CIK 0001521548

Halstead Michael

Reports to the SEC for 3 companies · TORONTO

sec.gov

Transactions

Companies

Filings

CIK

0001521548

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-21	HELPHelus Pharma Inc.P Purchase	Chief Executive Officer	PPurchase	+100K sh	$13.47	+$1.35M	168,568
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	President	DDisposition to Issuer	−40.5K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Performance Stock UnitsA Award	President	AAward	+13.1K sh	—	—	13,134
2025-04-02	Intra-Cellular Therapies, Inc.Restricted Stock UnitsD Disposition to Issuer	President	DDisposition to Issuer	−24.5K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Performance Stock UnitsD Disposition to Issuer	President	DDisposition to Issuer	−13.1K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	President	DDisposition to Issuer	−17.9K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Performance Stock UnitsD Disposition to Issuer	President	DDisposition to Issuer	−12.2K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Restricted Stock UnitsD Disposition to Issuer	President	DDisposition to Issuer	−45.5K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Restricted Stock UnitsD Disposition to Issuer	President	DDisposition to Issuer	−13.1K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Performance Stock UnitsA Award	President	AAward	+12.2K sh	—	—	12,240
2025-04-02	Intra-Cellular Therapies, Inc.D Disposition to Issuer	President	DDisposition to Issuer	−21.3K sh	$132.00	−$2.81M	0
2025-03-10	Intra-Cellular Therapies, Inc.M Exercise/Conversion	President	MExercise/Conversion	+7,345 sh	—	—	25,064
2025-03-10	Intra-Cellular Therapies, Inc.F Tax Payment	President	FTax Payment	−3,757 sh	$131.24	−$493K	21,307
2025-03-10	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	President	MExercise/Conversion	−7,345 sh	—	—	0
2025-03-06	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	President	MExercise/Conversion	−13.1K sh	—	—	13,133
2025-03-06	Intra-Cellular Therapies, Inc.M Exercise/Conversion	President	MExercise/Conversion	+13.1K sh	—	—	24,437
2025-03-06	Intra-Cellular Therapies, Inc.F Tax Payment	President	FTax Payment	−6,718 sh	$131.19	−$881K	17,719
2025-03-01	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	President	MExercise/Conversion	−12.2K sh	—	—	24,478
2025-03-01	Intra-Cellular Therapies, Inc.F Tax Payment	President	FTax Payment	−6,261 sh	$128.20	−$803K	11,304
2025-03-01	Intra-Cellular Therapies, Inc.M Exercise/Conversion	President	MExercise/Conversion	+12.2K sh	—	—	17,565
2025-02-03	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	President	AAward	+45.5K sh	—	—	45,454
2025-01-31	Intra-Cellular Therapies, Inc.F Tax Payment	President	FTax Payment	−5,691 sh	$127.00	−$723K	5,326
2025-01-31	Intra-Cellular Therapies, Inc.A Award	President	AAward	+11K sh	—	—	11,017
2024-11-13	Intra-Cellular Therapies, Inc.S Sale	President	SSale	−5,343 sh	$88.92	−$475K	0
2024-11-13	Intra-Cellular Therapies, Inc.S Sale	President	SSale	−13.4K sh	$88.17	−$1.18M	5,343
2024-11-13	Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion	President	MExercise/Conversion	−18.7K sh	—	—	0
2024-11-13	Intra-Cellular Therapies, Inc.M Exercise/Conversion	President	MExercise/Conversion	+18.7K sh	$36.89	+$690K	18,714
2024-11-12	Intra-Cellular Therapies, Inc.M Exercise/Conversion	President	MExercise/Conversion	+22.9K sh	$23.94	+$547K	22,869
2024-11-12	Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion	President	MExercise/Conversion	−22.9K sh	—	—	0
2024-11-12	Intra-Cellular Therapies, Inc.S Sale	President	SSale	−15.1K sh	$88.72	−$1.34M	7,764
2024-11-12	Intra-Cellular Therapies, Inc.S Sale	President	SSale	−6,116 sh	$89.63	−$548K	1,648
2024-11-12	Intra-Cellular Therapies, Inc.S Sale	President	SSale	−1,648 sh	$90.89	−$150K	0
2024-03-11	Intra-Cellular Therapies, Inc.S Sale	President	SSale	−6,107 sh	$65.82	−$402K	1,238
2024-03-11	Intra-Cellular Therapies, Inc.S Sale	President	SSale	−1,238 sh	$66.70	−$82.6K	0
2024-03-10	Intra-Cellular Therapies, Inc.M Exercise/Conversion	President	MExercise/Conversion	+7,345 sh	—	—	7,345
2024-03-10	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	President	MExercise/Conversion	−7,345 sh	—	—	7,345
2024-03-07	Intra-Cellular Therapies, Inc.S Sale	President	SSale	−220 sh	$66.81	−$14.7K	0
2024-03-07	Intra-Cellular Therapies, Inc.S Sale	President	SSale	−12.9K sh	$66.14	−$854K	220
2024-03-06	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	President	MExercise/Conversion	−13.1K sh	—	—	26,266
2024-03-06	Intra-Cellular Therapies, Inc.M Exercise/Conversion	President	MExercise/Conversion	+13.1K sh	—	—	13,132
2024-03-01	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	President	AAward	+36.7K sh	—	—	36,717
2024-02-26	Intra-Cellular Therapies, Inc.S Sale	President	SSale	−7,215 sh	$69.54	−$502K	392
2024-02-26	Intra-Cellular Therapies, Inc.S Sale	President	SSale	−392 sh	$70.13	−$27.5K	0
2024-02-26	Intra-Cellular Therapies, Inc.S Sale	President	SSale	−300 sh	$68.54	−$20.6K	7,607
2024-02-23	Intra-Cellular Therapies, Inc.M Exercise/Conversion	President	MExercise/Conversion	+7,907 sh	—	—	7,907
2024-02-23	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	President	MExercise/Conversion	−7,907 sh	—	—	0
2024-02-02	Intra-Cellular Therapies, Inc.S Sale	President	SSale	−714 sh	$67.17	−$48K	0
2024-02-02	Intra-Cellular Therapies, Inc.S Sale	President	SSale	−11.1K sh	$66.37	−$740K	714
2024-02-01	Intra-Cellular Therapies, Inc.A Award	President	AAward	+11.9K sh	—	—	11,860
2024-01-11	Intra-Cellular Therapies, Inc.M Exercise/Conversion	President	MExercise/Conversion	+46.1K sh	$12.73	+$587K	46,115

Recent filings

Accepted (ET)
Sep 214
Halstead Michael0000912282-26-001293
SEC(opens sec.gov)
Apr 24
Halstead Michael0000950170-25-049646
SEC(opens sec.gov)
Mar 104
Halstead Michael0000950170-25-036591
SEC(opens sec.gov)
Mar 44
Halstead Michael0000950170-25-032586
SEC(opens sec.gov)

Companies

Address

C/O CYBIN INC. 100 KING STREET W., SUITE 5600

TORONTO, M5X 1C9